Filtered By:
Procedure: Breast Conservation Surgery
Therapy: Endocrine Therapy

This page shows you your search results in order of date.

Order by Relevance | Date

Total 135 results found since Jan 2013.

Long-Term Patient-Reported Outcomes Comparing Oncoplastic Breast Surgery and Conventional Breast-Conserving Surgery: A Propensity Score-Matched Analysis
CONCLUSIONS: Women who undergo OBS present with a larger disease burden and may represent a group of non-traditional BCS candidates; they reported similar long-term breast satisfaction and sexual well-being compared with women who undergo BCS. While women who underwent OBS reported lower psychosocial well-being scores preoperatively and during a portion of the follow-up period, this difference was no longer seen at 5 years postoperatively.PMID:37556008 | DOI:10.1245/s10434-023-13962-x
Source: Ann Oncol - August 9, 2023 Category: Cancer & Oncology Authors: Linda M Pak Regina Matar-Ujvary Francys C Verdial Kathryn A Haglich Varadan Sevilimedu Jonas A Nelson Mary L Gemignani Source Type: research

Sarcopenia and toxicity-related discontinuation of endocrine therapy in women with early-stage hormone-receptor-positive breast cancer
Conclusion Among women with early-stage HR+ BC who receive adjuvant radiotherapy and ET, sarcopenia is associated with toxicity-related early discontinuation of aET. Further studies should validate these findings in women who did not receive adjuvant RT. These high-risk patients may be candidates for aggressive symptom management and/or alternative treatment strategies to improve outcomes.PMID:37506979 | DOI:10.1016/j.ijrobp.2023.07.018
Source: Health Physics - July 28, 2023 Category: Physics Authors: Anurag Saraf Ismail Tahir Bonnie Hu Anna-Sophia W Dietrich P Erik Tonnesen Gregory C Sharp Gayle Tillman Eric J Roeland Ryan D Nipp Amy Comander Jeffery Peppercorn Florian J Fintelmann Rachel B Jimenez Source Type: research

Acute skin toxicity of ultra-hypofractionated whole breast radiotherapy with simultaneous integrated boost for early breast cancer
CONCLUSION: Ultra-hypofractionated WBI + SIB in 5 fractions over one-week is feasible and well tolerated, although longer follow-up is necessary to confirm these results.PMID:37388711 | PMC:PMC10300060 | DOI:10.1016/j.ctro.2023.100651
Source: Clinical Breast Cancer - June 30, 2023 Category: Cancer & Oncology Authors: Angel Montero Raquel Ci érvide Carmen Ca ñadillas Beatriz Álvarez Mariola Garc ía-Aranda Rosa Alonso Mercedes L ópez Xin Chen-Zhao Leyre Alonso Jeannete Valero Emilio S ánchez Ovidio Hernando Paz Garc ía de Acilu Pedro Fernandez-Let ón Carmen Rubi Source Type: research

Associations Between Hospital Volume and Overall Survival After Surgery in Older Patients with Breast Cancer
CONCLUSIONS: Among patients with breast cancer age ≥ 80 years, undergoing surgery at a HVH was associated with improved OS. Patients who completed surgery at HVHs had earlier stage disease and more commonly received adjuvant radiation when appropriate. Processes of care at HVHs should be identified to improve outcomes in all settings.PMID:37314545 | DOI:10.1245/s10434-023-13725-8
Source: Ann Oncol - June 14, 2023 Category: Cancer & Oncology Authors: Sam Z Thalji Chandler S Cortina Julia Frebault Youngjoo Cho Abigail Thorgerson Carmen R Bergom Chiang-Ching Huang Amanda L Kong Source Type: research

The Impact of Breast-Conserving Surgery Re-excision on Patient-Reported Outcomes Using the BREAST-Q
CONCLUSIONS: Women with R-BCS had lower breast satisfaction and sexual well-being 2 years postoperatively, but this difference did not remain long term. Psychosocial well-being in women who underwent one BCS were largely comparable over time to the R-BCS group. These findings may help in counseling women who are concerned about satisfaction and quality-of-life outcomes with BCS if re-excision is necessary.PMID:37306849 | DOI:10.1245/s10434-023-13592-3
Source: Ann Oncol - June 12, 2023 Category: Cancer & Oncology Authors: Regina Matar-Ujvary Kathryn Haglich Meghan R Flanagan Sarah Fuzesi Varadan Sevilimedu Jonas A Nelson Mary L Gemignani Source Type: research

Long-term outcomes of intraoperatively-placed applicator brachytherapy for rapid completion of breast conserving treatment: An analysis of a prospective registry data
CONCLUSIONS: Postmenopausal status, BMI < 30 kg/m2, and ET- adherence predicted favorable IBTRFS. Our results highlight the importance of careful patient selection for ABB and encouragement of ET compliance.PMID:37251618 | PMC:PMC10212787 | DOI:10.1016/j.ctro.2023.100639
Source: Clinical Breast Cancer - May 30, 2023 Category: Cancer & Oncology Authors: Haeyoung Kim Tina J Hieken Feven Abraha James W Jakub Kimberly S Corbin Keith M Furutani Judy C Boughey Bradley J Stish Christopher L Deufel Amy C Degnim Dean A Shumway Safia K Ahmed Mara A Piltin Nicole P Sandhu Amy L Conners Kathryn J Ruddy Robert W Mut Source Type: research

To Radiate or Not to Radiate After Breast-Conserving Surgery-Endocrine Therapy is the Question
Ann Surg Oncol. 2023 May 23. doi: 10.1245/s10434-023-13665-3. Online ahead of print.NO ABSTRACTPMID:37219655 | DOI:10.1245/s10434-023-13665-3
Source: Ann Oncol - May 23, 2023 Category: Cancer & Oncology Authors: Sumana Narayanan Roshni Rao Source Type: research